| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |